Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.25% | 4.91% | -42.73% | -41.76% | -8.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.25% | 4.91% | -42.73% | -41.76% | -8.91% |
| Cost of Revenue | 7.48% | 11.34% | 0.40% | 2.12% | 7.75% |
| Gross Profit | -1.56% | 1.99% | -57.45% | -56.75% | -14.89% |
| SG&A Expenses | -19.03% | -16.09% | -42.99% | -42.03% | -20.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -240.25% | -246.89% | -32.28% |
| Total Operating Expenses | 2.83% | 6.55% | -38.66% | -37.62% | -14.97% |
| Operating Income | -6.82% | -10.66% | 24.32% | 23.05% | 27.26% |
| Income Before Tax | -2.65% | -6.39% | -63.02% | -65.78% | 19.33% |
| Income Tax Expenses | -- | -- | 0.00% | 0.00% | -- |
| Earnings from Continuing Operations | -2.47% | -6.20% | -63.15% | -65.88% | 19.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.47% | -6.20% | -63.15% | -65.88% | 19.19% |
| EBIT | -6.82% | -10.66% | 24.32% | 23.05% | 27.26% |
| EBITDA | -7.17% | -11.04% | 30.23% | 29.10% | 29.45% |
| EPS Basic | 60.00% | 60.00% | 25.00% | 25.00% | 16.67% |
| Normalized Basic EPS | 66.67% | 66.67% | 66.67% | 66.67% | 25.00% |
| EPS Diluted | 60.00% | 60.00% | 25.00% | 25.00% | 16.67% |
| Normalized Diluted EPS | 66.67% | 66.67% | 66.67% | 66.67% | 25.00% |
| Average Basic Shares Outstanding | 169.04% | 169.04% | 137.43% | 137.43% | 4.62% |
| Average Diluted Shares Outstanding | 169.04% | 169.04% | 137.43% | 137.43% | 4.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
